Business
CannaPharmaRx to Exhibit at the Cannabis World Congress & Business Expo in NYC
CannaPharmaRx to Exhibit at the Cannabis World Congress & Business Expo in NYC.
About this update from Cannapharmarx Inc.
[{"type":"text","content":"\nCannaPharmaRx to Exhibit at the Cannabis World Congress & Business Expo in NYC \n\nCannaPharmaRx to Exhibit at the Cannabis World Congress & Business Expo in NYC\n\nCARNEYS POINT, NJ--(Marketwired - June 17, 2015) - CannaPharmaRx, Inc. (OTCQB: CPMD), a leader in the research, development, and commercialization of cannabinoid-based drug products, announced today that it will be exhibiting at the 2nd Annual Cannabis World Congress & Business Expo. The conference will be held at the Jacob Javits Center in New York, NY from Wednesday, June 17 through Friday, June 19. CannaPharmaRx will exhibit in booth # 316.The Cannabis World Congress & Business Expo is the definitive business event for the cannabis industry. Exhibitors and sponsors bring cutting-edge solutions to owners and managers of businesses in this fast-growing industry, and a wealth of opportunity and knowledge to those looking to enter the market with potential partners and investors. This year, over 90 business will be showcasing the latest technologies, solutions, and resources of the cannabis industry.About CannaPharmaRx, Inc.CannaPharmaRx, Inc. is an early-stage pharmaceutical company whose purpose is to advance cannabinoid research and discovery using proprietary formulation and drug delivery technology currently in development. Cannabinoids are a class of chemicals that, once ingested, are active in humans and animals through the \"endocannabinoid system\" -- one of the most widely expressed system of receptors in the human body. CannaPharmaRx is currently focused on targeting disease states where its delivery systems can have optimal impact with therapeutic differentiation among alternative cannabinoid therapies, including: insomnia, neurological disorders, oncology, infectious disease, pain management, inflammatory disease, gastrointestinal disorders and ophthalmology. For more information, please visit www.CannaPharmaRx.com. Forward-Looking StatementsCertain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as \"anticipate,\" \"believe,\" \"forecast,\" \"estimated,\" and \"intend\" among others. These forward-looking statements are based on CannaPharmaRx's current expectations and actual result...